New York, NY, May 10, 2019 --(PR.com
)-- This event is scheduled for Monday, May 20, 2019 @ 12:00 pm - 1:00 pm (ET).
For further details, please visit: https://www.theknowledgegroup.org/webcasts/navigating-mass-torts-litigation/
About Mark K. Silver
Mark K. Silver is a Partner in Coughlin Duffy LLP’s Commercial Services group where he regularly handles matters involving the following practice areas: mass torts, products liability, pharmaceutical litigation and general commercial litigation. Over the past decade, Mark has defended several major product and pharmaceutical manufacturers in a variety of legal arenas including acting as lead local counsel in a the talc multi-district federal litigation. Mark has successfully defended several significant product liability actions including the defense of a large industrial machinery manufacturer against a claim that its product was defectively designed. Mark received his J.D. and Master’s degree from Syracuse University, magna cum laude, and his B.A. from The George Washington University. Mark is admitted to the bar in New Jersey, New York and Pennsylvania.
About Coughlin Duffy LLP
Coughlin Duffy LLP is a diverse, full-service firm committed to providing legal services of exceptional quality and superior value. We serve regional, national, and international clients, bringing to each matter the energy, experience, and imagination of a talented group of lawyers and staff dedicated to obtaining optimal results and to fulfilling the highest standards of the profession.
A large number of mass torts filed over the previous year involve drugs including Xarelto, Risperdal, Opioids and Pradaxa. One notable case is the mass tort against pharmaceutical giant Hoffmann La-Roche with over 500 lawsuits claiming that users of the company’s acne drug Accutane, developed inflammatory bowel disease. The New Jersey Supreme Court ruled in favor of Hoffmann La-Roche with its dismissal of the mass tort case. The Court said that the plaintiffs failed to prove that Roche failed to provide internal research to the Food and Drug Administration (FDA).
Understanding mass tort case verdicts such as this, as well as the upcoming ones, is critical in devising effective litigation strategies.
Join a panel of key thought leaders and professionals assembled by The Knowledge Group as they bring the audience to a road beyond the basics of bringing or defending against a mass tort lawsuit and as they delve into the depth-analysis of the current trends and recent court rulings. Speakers will also provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.
Some of the major topics that will be covered in this course are:
Mass Torts Litigation – Overview and Statistics
Recent Trends and Developments
Notable Cases and Verdicts
Top Issues and Challenges
Best Litigation Strategies
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/